SSX6 antibody (Middle Region)
-
- Target See all SSX6 products
- SSX6 (Synovial Sarcoma, X Breakpoint 6 (Pseudogene) (SSX6))
-
Binding Specificity
- Middle Region
- Reactivity
- Human
-
Host
- Rabbit
-
Clonality
- Polyclonal
-
Conjugate
- This SSX6 antibody is un-conjugated
-
Application
- Western Blotting (WB)
- Purification
- Purified
- Immunogen
- SSX6 antibody was raised in rabbit using the middle region of SSX6 as the immunogen
-
-
- Application Notes
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. - Comment
-
SSX6 Blocking Peptide, catalog no. 33R-4093, is also available for use as a blocking control in assays to test for specificity of this SSX6 antibody
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Concentration
- Lot specific
- Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- 4 °C/-20 °C
- Storage Comment
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
- Target
- SSX6 (Synovial Sarcoma, X Breakpoint 6 (Pseudogene) (SSX6))
- Alternative Name
- SSX6 (SSX6 Products)
- Synonyms
- SSXP2 antibody, dJ54B20.1 antibody, psiSSX2 antibody, SSX family member 6, pseudogene antibody, SSX6 antibody
- Background
- SSX6 belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. Synonyms: Polyclonal SSX6 antibody, Anti-SSX6 antibody, synovial sarcoma, X breakpoint 6 antibody, dJ54B20.1 antibody.
-